gw-501516
Trade name: Cardarine
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started Apr 1, 2003 (NCT00841217)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Androgen ReceptorAGONIST
AR agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- endurobol
- gw1516
- gw 1516
- gw-1516
- gw501516
- gw501516
- gw501516
- gw 501516
- gw-501516
- gw-501516
- gw510516
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00158899 | Phase 2 | Aug 1, 2004 | GlaxoSmithKline |
| NCT00841217 | Phase 4 | Apr 1, 2003 | National Heart Foundation, Australia, University of Western Australia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2004 |
| National Heart Foundation, Australia | Government | 1 | 0 | 1 | 2003 |
| University of Western Australia | Academic/Hospital | 1 | 1 | 1 | 2003 |
3 organizations
Page 1 / 1